Christine Coughlin, MD, PhD, on TRACK-NK Technology in Non-Small Cell Lung Cancer ByChristine Coughlin, MD, PhDOctober 5th 2022The chief executive officer of Cytoimmune discussed the company’s technology platforms and programs.